Trial of 3-weekly Versus 5-weekly Schedule of S-1 Plus Cisplatin in Gastric Cancer: SOS

NCT00915382 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

625

Enrollment

OTHER

Sponsor class

Conditions

Advanced Gastric Cancer

Interventions

DRUG: S-1 and cisplatin
DRUG: S-1 and cisplatin

Sponsor

Asan Medical Center

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]